Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Baylor

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Global Health|October 20, 2023
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countriesBirgitte K Giersing, Richard Isbrucker, David C Kaslow, et al.
Science Translational Medicine|April 16, 2025
Vaccinology in the artificial intelligence eraGianmarco Gasperini, Norman Baylor, Steve Black, et al.
Influenza and Other Respiratory Viruses|August 9, 2011
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Global Health|October 20, 2023
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countriesBirgitte K Giersing, Richard Isbrucker, David C Kaslow, et al.
Science Translational Medicine|April 16, 2025
Vaccinology in the artificial intelligence eraGianmarco Gasperini, Norman Baylor, Steve Black, et al.
Influenza and Other Respiratory Viruses|August 9, 2011
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010, William K Ampofo, Norman Baylor, et al.
Pageof 1